by The Welsh Aspirin Group Peter Elwood, Gareth Morgan, Richard Adams, Christine Delon, Marcus Longley, Simon Noble, Janet Pickering, Majd Protty, John Watkins, Anna Yeatman Corresponding author: Gareth Morgan ABSTRACT: Aspirin is a remarkable drug that has been shown in more than fifty years of research to be beneficial at Read more
Myeloproliferative neoplasms (MPN’s) are a group of blood cancers. MPN’s are bone marrow disorders which results in an excess of blood cells. As a result, these blood cancers are associated with risks of clots and low-dose aspirin is often used in many patients along with other treatments. There are three Read more
Addendum: Since publishing this article, two trials have been subsequently published on aspirin and bowel cancer. They have mixed results and neither study found a statistically significant effect. The table and the commentary will be updated in due course to take account of these studies. (WAG 13/7/2026) https://ascopubs.org/doi/10.1200/JCO.2025.43.17_suppl.LBA3511 https://ascopubs.org/doi/10.1200/JCO.2026.44.17_suppl.LBA3508 Abstract Read more
An abstract by Dr Gareth Morgan, John Watkins, Majad Protty and Professor Peter Elwood Click image for link to the article.
There are four basic ethical principles in clinical practice: non-maleficence; beneficence; autonomy and justice. Evidence upon which each of these is judged comes from appropriate research, but there are also personal opinions and claims – many of which are supported by little, if any, research evidence. The evaluation of evidence Read more
Aspirin and the Prevention of Cancer: The Emerging Evidence – Cardiff University School of Medicine.